R. Armstrong

发表

Chromatin Accessibility Landscape of Cutaneous T Cell Lymphoma and Dynamic Response to HDAC Inhibitors.

Howard Y. Chang, Ansuman T. Satpathy, H. Ueno, 2017, Cancer cell.

Donor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid Neoplasms.

R. Negrin, E. Meyer, R. Armstrong, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project.

R. Advani, G. Wood, S. Horwitz, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Infusion of donor-derived CD8+ memory T cells for relapse following allogeneic hematopoietic cell transplantation.

D. Miklos, R. Negrin, L. Muffly, 2018, Blood advances.

Freeze and Thaw of CD4+CD25+Foxp3+ Regulatory T Cells Results in Loss of CD62L Expression and a Reduced Capacity to Protect against Graft-versus-Host Disease

M. Florek, R. Negrin, E. Meyer, 2015, PloS one.

Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients.

D. Miklos, B. Sahaf, Sai-Wen Tang, 2019, JCI insight.

Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation.

D. Miklos, R. Negrin, R. Armstrong, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts.

Howard Y. Chang, Carolyn S. Lee, Richard O. Chen, 2012, Blood.

High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment

James L. Zehnder, Wenzhong Xiao, Ismael Buño, 2011, Proceedings of the National Academy of Sciences.

Antibodies specifically target AML antigen NuSAP1 after allogeneic bone marrow transplantation.

A. Butte, Marc Coram, M. Mindrinos, 2010, Blood.

Minimal Residual Disease Monitoring with High-Throughput Sequencing of T Cell Receptors in Cutaneous T Cell Lymphoma

C. Desmarais, R. Hoppe, Youn H. Kim, 2013, Science Translational Medicine.

4.11 High-Throughput VDJ Sequencing for Chronic Lymphocytic Leukemia: Minimal Residual Disease Quantification and Immunoglobulin Repertoire Assessment Following Hematopoietic Cell Transplantation

A. Fire, W. Xiao, M. Mindrinos, 2011, Clinical Lymphoma Myeloma and Leukemia.

Brentuximab Vedotin Demonstrates Significant Clinical Activity in Relapsed or Refractory Mycosis Fungoides with Variable CD30 Expression

R. Advani, G. Wood, S. Horwitz, 2012 .

The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T‐cell lymphoma patients

K. Sutherland, L. Showe, A. Rook, 2012, American journal of hematology.

Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2

Ashley M. Zehnder, Carolyn S. Lee, Michael P. Snyder, 2015, Nature Genetics.

Donor-Derived CIK Cell Infusion As Consolidative Therapy after Non-Myeloablative Allogeneic Transplant in Patients with Myeloid Neoplasms

L. Tian, D. Miklos, R. Negrin, 2015 .

A Phase I Study of Donor Regulatory T Cells As Treatment for Steroid Dependent/Refractory Chronic Graft Versus Host Disease

D. Miklos, B. Sahaf, R. Negrin, 2016 .

Non-Myeloablative Allogeneic Transplantation Resulting in Clinical and Molecular Remission with Low Non-Relapse Mortality (NRM) in Patients with Advanced Stage Mycosis Fungoides (MF) and Sézary Syndrome (SS)

D. Miklos, R. Hoppe, R. Negrin, 2014 .